相关实验视频
Updated: Jan 6, 2026

07:29
Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
8.1K
快速与标准诱导注射延长释放布普伦诺芬:一个随机临床试验
Rajinder Shiwach1, Bernard Le Foll2, Hannu Alho3
1InSite Clinical Research, Desoto, Texas.
JAMA network open
|October 14, 2025
概括
布普伦诺芬-纳洛的快速诱导 (RI) 显示,在阿片类药物使用障碍治疗中,其保留率高于标准诱导 (SI). 这种方法是有效的,特别是对于使用芬太尼的患者,并且耐受性很好.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 超粘膜布诺芬-纳洛的标准诱导 (SI) 对高剂量,注射或合成阿片类药物使用的个人构成挑战.
- 阿片类药物使用障碍 (OUD) 治疗需要针对不同患者群体的有效诱导方法.
研究的目的:
- 为了比较快速诱导 (RI) 与SI的有效性和安全性,其次是延长释放布诺芬注射.
- 为了评估在接受不同诱导方案的OUD患者的保留率和不良事件.
主要方法:
- 一个多中心的,开放的,随机的临床试验,涉及729名参与者中度至重度OUD.
- 在接受延长释放布伦诺芬注射之前,参与者被随机分配到RI (4mg单剂量) 或SI (≥7天).
- 主要终点是第二次注射的保留率,使用贝叶斯方法进行分析. 亚组分析包括芬太尼的使用.
主要成果:
- 在第二次注射 (11.8%的差异) 中,RI表现出非劣质性,在第二次注射时,其保留率高于SI (11.8%的差异).
- 在测试芬太尼阳性结果的参与者中,RI显示保留率高出14.8%.
- 在RI和SI组之间,不良事件发生率相似,大多数事件与阿片类药物戒断有关.
结论:
- 布普伦诺芬-纳洛的快速诱导 (RI) 与OUD中延长释放布普伦诺芬治疗的标准诱导 (SI) 相比,提供更好的保留.
- 对于使用芬太尼的患者来说,RI特别有益,并且耐受性良好.
- 在一周后进行第二次注射,可以优化治疗水平和患者留守率.
相关概念视频
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
221
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
221
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
209
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
209
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872
Bioequivalence studies: Biowaivers
197
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
197
Bioavailability Study Design: Single Versus Multiple Dose Studies
170
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
170
Drug Delivery: Parenteral Route
1.4K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.4K

